Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2016, Article ID 4161439, 4 pages
http://dx.doi.org/10.1155/2016/4161439
Case Report

Catastrophic Antiphospholipid Syndrome

1Rheumatology Department, Faculty of Medicine, Minia, Egypt
2Neurology Department, Faculty of Medicine, Minia, Egypt
3Cardiology Department, Faculty of Medicine, Minia, Egypt
4ICU Department, Faculty of Medicine, Minia, Egypt
5Radiology Department, Faculty of Medicine, Minia, Egypt

Received 15 February 2016; Revised 5 May 2016; Accepted 12 May 2016

Academic Editor: Gregory J. Tsay

Copyright © 2016 Rawhya R. El-Shereef et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. A. Asherson, R. Cervera, P. G. De Groot et al., “Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines,” Lupus, vol. 12, no. 7, pp. 530–534, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Cervera, J.-C. Piette, J. Font et al., “Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients,” Arthritis and Rheumatism, vol. 46, no. 4, pp. 1019–1027, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. R. A. Asherson, G. Espinosa, S. Menahem et al., “Relapsing catastrophic antiphospholipid syndrome: report of three cases,” Seminars in Arthritis and Rheumatism, vol. 37, no. 6, pp. 366–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Sciascia, C. Lopez-Pedrera, D. Roccatello, and M. J. Cuadrado, “Catastrophic antiphospholipid syndrome (CAPS),” Best Practice and Research: Clinical Rheumatology, vol. 26, no. 4, pp. 535–541, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. A. Asherson, R. Cervera, J.-C. Piette et al., “Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients,” Medicine, vol. 77, no. 3, pp. 195–207, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Cervera, J. Font, J. A. Gómez-Puerta et al., “Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome,” Annals of the Rheumatic Diseases, vol. 64, no. 8, pp. 1205–1209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Cervera, S. Bucciarelli, M. A. Plasín et al., “Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the <CAPS Registry>,” Journal of Autoimmunity, vol. 32, no. 3-4, pp. 240–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Giannakopoulos and S. A. Krilis, “The pathogenesis of the antiphospholipid syndrome,” The New England Journal of Medicine, vol. 368, no. 11, pp. 1033–1044, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Pengo, A. Tripodi, G. Reber et al., “Update of the guidelines for lupus anticoagulant detection,” Journal of Thrombosis and Haemostasis, vol. 7, no. 10, pp. 1737–1740, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. Khamashta, M. J. Cuadrado, F. Mujic, N. A. Taub, B. J. Hunt, and G. R. V. Hughes, “The management of thrombosis in the antiphospholipid-antibody syndrome,” The New England Journal of Medicine, vol. 332, no. 15, pp. 993–997, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Cervera and CAPS Registry Project Group, “Catastrophic antiphospholipid syndrome (CAPS): update from the ‘CAPS Registry’,” Lupus, vol. 19, no. 4, pp. 412–418, 2010. View at Publisher · View at Google Scholar
  13. C. M. Neuwelt, D. I. Daikh, J. A. Linfoot et al., “Catastrophic antiphospholipid syndrome. Response to repeated plasmapheresis over three years,” Arthritis and Rheumatism, vol. 40, no. 8, pp. 1534–1539, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Boura, S. Papadopoulos, K. Tselios et al., “Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case,” Clinical Rheumatology, vol. 24, no. 4, pp. 420–424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Bucciarelli, G. Espinosa, R. Cervera et al., “Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2568–2576, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. U. D. Bayraktar, D. Erkan, S. Bucciarelli, G. Espinosa, R. Asherson, and Catastrophic Antiphospholipid Syndrome Project Group, “The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus,” Journal of Rheumatology, vol. 34, no. 2, pp. 346–352, 2007. View at Google Scholar · View at Scopus